AMGEN INC (AMGN) Costs and Expenses USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Amgen Inc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2024.
  • Amgen Inc Costs and Expenses for the quarter ending March 31, 2024 was $6.46 B, a 54.3% increase year-over-year.
  • Amgen Inc Costs and Expenses for the twelve months ending March 31, 2024 was $22.6 B, a 31.2% increase year-over-year.
  • Amgen Inc annual Costs and Expenses for 2023 was $20.3 B, a 21.1% increase from 2022.
  • Amgen Inc annual Costs and Expenses for 2022 was $16.8 B, a 8.63% decline from 2021.
  • Amgen Inc annual Costs and Expenses for 2021 was $18.3 B, a 12.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $22.6 B $6.46 B +$2.27 B +54.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $20.3 B $6.93 B +$2.32 B +50.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $18 B $4.88 B +$890 M +22.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $17.1 B $4.3 B -$116 M -2.63% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $17.2 B $4.18 B +$446 M +11.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $16.8 B $4.61 B +$67 M +1.48% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $16.7 B $3.99 B -$336 M -7.76% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $17 B $4.42 B -$1.28 B -22.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $18.3 B $3.74 B -$34 M -0.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $18.3 B $4.54 B -$84 M -1.82% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $18.4 B $4.33 B +$358 M +9.02% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $18.1 B $5.7 B +$1.82 B +46.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $16.3 B $3.77 B -$34 M -0.89% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $16.3 B $4.63 B +$477 M +11.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $15.8 B $3.97 B +$709 M +21.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $15.1 B $3.88 B +$690 M +21.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $14.4 B $3.81 B +$721 M +23.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $13.7 B $4.15 B +$301 M +7.82% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $13.4 B $3.26 B -$320 M -8.94% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $13.7 B $3.19 B -$34 M -1.05% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $13.7 B $3.09 B +$257 M +9.09% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $13.5 B $3.85 B +$291 M +8.18% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $13.2 B $3.58 B +$247 M +7.41% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $12.9 B $3.23 B +$115 M +3.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $12.8 B $2.83 B -$45 M -1.57% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $12.9 B $3.56 B +$77 M +2.21% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $12.8 B $3.33 B +$50 M +1.52% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $12.7 B $3.11 B -$196 M -5.93% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $12.9 B $2.87 B -$252 M -8.06% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $13.2 B $3.48 B -$23 M -0.66% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $13.2 B $3.28 B -$100 M -2.96% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $13.3 B $3.31 B +$14 M +0.43% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $13.3 B $3.13 B +$114 M +3.79% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $13.2 B $3.5 B -$369 M -9.53% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $13.6 B $3.38 B -$181 M -5.08% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $13.7 B $3.29 B +$16 M +0.49% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $13.7 B $3.01 B -$146 M -4.63% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $13.9 B $3.87 B +$48 M +1.26% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $13.8 B $3.57 B +$505 M +16.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $13.3 B $3.28 B +$149 M +4.76% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $13.2 B $3.16 B +$361 M +12.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $12.8 B $3.82 B +$491 M +14.7% Oct 1, 2013 Dec 31, 2013 8-K 2016-10-31
Q3 2013 $12.3 B $3.06 B +$164 M +5.66% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $12.2 B $3.13 B +$241 M +8.35% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $11.9 B $2.8 B +$225 M +8.75% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $11.7 B $3.33 B +$522 M +18.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $11.2 B $2.9 B -$523 M -15.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $11.7 B $2.89 B +$261 M +9.94% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $11.4 B $2.57 B +$158 M +6.55% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $11.3 B $2.81 B +$38 M +1.37% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $11.2 B $3.42 B +$1.08 B +46.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $10.2 B $2.63 B +$340 M +14.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $9.81 B $2.41 B +$302 M +14.3% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $9.51 B $2.77 B Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $2.34 B Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $2.29 B Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $2.11 B Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.